| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3145 |
| Trial ID | NCT05487651 |
| Disease | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma | B-Cell Leukemia | Childhood Acute Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | KUR-502 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies |
| Year | 2022 |
| Country | United States |
| Company sponsor | Athenex, Inc. |
| Other ID(s) | ATX-K502-001 |
| Cohort 1 | |||||||||||||
|
|||||||||||||